PharmaTimes -
Nov/Dec 2015


Global M&A hits all-time high
9Post-antibiotic' era draws nearer
Divisive plans for new-look CDF
UK paying less for cancer drugs than EU
NICE under attack
GPs 'failing as a profession'
Huge demand for diabetes programme


Is merger mania on the wane?
2015 was a record-breaking year for mergers and acquisitions but what does 2016 hold?

University challenge
Who will win in the battle between Oxford and Cambridge to become the UK's top biotech cluster?

Failure to launch
A new report delves into why so many pharma brands struggle to launch and what can be done about it

Compliance complacency?
How companies can transform their compliance function from a burden to a benefit

Matching mutation to medicine
Will linking diagnostic tests for cancer to treatment deliver the promise of personalised medicine

Blood pressure
The race to the top of the anticoagulant market


Review of 2015
A look back at the biggest stories in pharma and healthcare from 2015, with opinions and analysis from industry experts


Best behaviour
Jane Asscher from 23red explains what makes a successful public health campaign

Aspiring marketer Matt Callaghan discusses the challenges of working in three different countries, his foray into strategic marketing and excitement at winning a prestigious award

This month's job moves and new appointments

Patient Files
How stroke patient Fleur Costello's life was saved by a garbled Facebook message

Latest jobs from #PharmaRole

View all

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.